🟢 Immunic is trading 5.4% up today amid renewed biotech M&A optimism

Immunic is trading 5.4% up at $14.77, with the move driven primarily by a biotech-sector rally.

• Biotech ETF XBI is up 2.09% on August 6, 2026, following renewed merger-and-acquisition optimism after Argenx’s Forte Biosciences tender offer.
• Immunic is approaching its scheduled Q2 earnings report, but no company-specific results were available by 10:12 a.m. Eastern Time.